About Us
Empowering Global Health with Decades of Excellence
Established in 1984, Aarti Drugs Ltd. is a key member of the $900 million Aarti Group of Industries. With a strong R&D base located at Tarapur in the Maharashtra Industrial Development Corporation (MIDC), the company benefits from strategic proximity to its manufacturing units.
Aarti Drugs specializes in the production of Active Pharmaceutical Ingredients (APIs). Pharma Intermediates - Specialty ChemicalsFormulations – manufactured through its wholly-owned subsidiary, Pinnacle Life Science Private Limited and formulation marketing overseas subsidiaries, Pinnacle Chie SpA and Pharma Go SpA.
- Strategic Growth, Scientific Vision.
- Four Decades of Pharmaceutical Leadership.
Our Mission
To achieve global market leadership by driving continuous growth and innovation in our products. We are committed to cultivating a winning culture grounded in the highest standards of ethics and values, promoting collaboration even among competitors. We strive for excellence in customer service, product quality, and research & development, ensuring we deliver exceptional value and lasting impact in everything we do.
Our Vision
One of the largest prodTo become the first-choice vendor for bulk drugs by delivering consistent quality and ensuring timely delivery at competitive prices. We are committed to providing customized solutions and services that adapt to the evolving needs of our customers. We will adopt the best and most flexible manufacturing practices, supported by proven, safe, and cost-effective technologies. Our focus remains on continuous technology upgrades, ethical business conduct, and innovative product development to foster long-term customer satisfaction and industry leadership.
Business Interest
Bulk Drugs & Chemicals
Aarti Drugs Ltd. can be looked at as a reliable source of Generic Bulk Actives, Advanced Intermediates and Specialty Chemicals.
Confidential Manufacturing
Scale-up of Customer's Processes to manufacture products as per customer's requirements in strictestconfidence.
Commitment to Quality and Compliance
Excellence Through Quality Culture
At Aarti Drugs, we strive to become synonymous with quality by not only meeting but exceeding our customers’ standards—achieved through a deep understanding of their needs and flawless execution.
- Engage Continuously: Maintain open, ongoing dialogue with customers to capture and anticipate their precise quality requirements.
- First Time Right: Translate customer expectations directly into our plant processes to ensure “right-first-time, right-every-time” performance.
- Quality Culture: Inspire every team member to embrace quality consciousness in their role and pursue continual yield and process improvements.
- Collaborative Partnerships: Foster proactive, system driven teamwork with suppliers and customers, developing them into true business partners.
Globalization & Export Overview
Global expansion remains a core focus for Aarti Drugs Ltd. Our concerted efforts in this area have driven robust growth in the export of APIs and specialty chemicals. We continue to prioritize niche segments and deepen our presence in regulated markets to sustain long term international success.
- Agility & Reliability: Rapid response times, competitive pricing and unwavering commitments ensure we deliver “right first time” solutions to customers worldwide.
- Extensive Reach: Today, our products serve more than 100 countries, cementing our role as a trusted source of bulk actives and intermediates.
- Premier Clientele: We proudly partner with leading MNCs—including Sanofi Aventis, Merck, Teva, Searle, Pfizer, Bayer and Clariant—providing them with high quality APIs and specialty chemicals.
- Government Recognized Export House: Accredited for many years, this status underscores our consistent export performance and adherence to international standards.
Regulatory & Quality Compliance
Aarti Drugs Ltd. upholds the highest standards of documentation and regulatory readiness across its operations:
- Comprehensive DMF Portfolio: Drug Master Files (DMFs) in CTD format are available for nearly the entire product range, with four additional filings currently under preparation.
- Specialty Chemicals Excellence: Our specialty chemicals plant is ISO 9002 certified, reflecting strong process control and quality management systems.
- USFDA-Compliant Infrastructure: The intermediate plant supporting our USFDA-approved facility is ISO 9001:2000 certified, ensuring compliance with global regulatory and quality benchmarks.
Our Leadership Team
Aarti Drugs Ltd. is guided by a dynamic and experienced leadership team committed to driving innovation, operational excellence, and sustainable growth across global markets:
- Experienced Team Members: Industry experts with years of experience guide the company’s growth and strategic direction.
- Operational Excellence: Team members lead efficient operations, ensure compliance, and foster innovation to keep Aarti Drugs Ltd. ahead in the market.
- Strong Governance: The team upholds ethical practices, transparency, and high standards of corporate governance.
Recognitions of Excellence
Aarti Drugs Ltd. has been consistently acknowledged for its excellence in export performance, vendor reliability, and business partnerships by reputed industry and government bodies:
- Export & Government Recognition: Honored by CHEMEXCIL, PHARMEXCIL, and the Ministry of Commerce for outstanding export performance and certified as a Star Export House.
- Business Partnerships: Awarded by ABBOTT, CHEMEXCIL, and others for consistent excellence as a trusted vendor and partner.
- Customer Service Excellence: Honored by AVAYA GLOBAL CONNECT for exceptional customer responsiveness in 2005 and 2006.
Our Journey Map
Stock Market Milestone
Winning a research award is a significant achievement and a testament to your hard work, dedication, and contributions to your field of study.
Strategic Amalgamation
The year 1996 marked the amalgamation of Aarti Drugs with seven entities, including Rupal Chemical Industries Ltd., Rashesh Chemicals & Pharmaceuticals Ltd., Manjarati Chemicals Pvt. Ltd., Manjarati Plastisizer Pvt. Ltd., Effective Chemicals Pvt. Ltd., Star Aluminium Industries Ltd., and Avez Wire.
Major Acquisition
Turnover of $116.92 million USD 100% holdings in Pinnacle Life Science Pvt. Ltd.
Record-Breaking Year
Crossed $233.84 million USD in consolidated turnover and $23.38 million USD formulation turnover. Crossed Profit After Tax of $23.38 million USD.
New Market Entry
Forayed into the personal care segment with the commissioning of a greenfield project for dermatology products at Tarapur.